Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Gimadutdinov RF"'
Autor:
Litvinenko IV; S.M. Kirov Saint-Petersburg Military Medical Academy, St-Petersburg, Russia., Dynin PS; S.M. Kirov Saint-Petersburg Military Medical Academy, St-Petersburg, Russia., Trufanov AG; S.M. Kirov Saint-Petersburg Military Medical Academy, St-Petersburg, Russia., Gimadutdinov RF; S.M. Kirov Saint-Petersburg Military Medical Academy, St-Petersburg, Russia., Maltsev DS; S.M. Kirov Saint-Petersburg Military Medical Academy, St-Petersburg, Russia.
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2018; Vol. 118 (6. Vyp. 2), pp. 105-114.
Autor:
Juan Segura-Aguilar
More than 50 years have passed since the use of L-dopa in the palliative treatment of Parkinson's disease, but it remains the most common treatment despite inducing severe side effects such as dyskinesia after 4–6 years of use. Numerous preclinical
